4 results
PP02 Is Glycated Hemoglobin A Valid Surrogate Endpoint To Evaluate The Effectiveness Of Drugs In Diabetes Mellitus Studies?
-
- Journal:
- International Journal of Technology Assessment in Health Care / Volume 38 / Issue S1 / December 2022
- Published online by Cambridge University Press:
- 23 December 2022, p. S39
-
- Article
-
- You have access
- Export citation
Glycated hemoglobin as a surrogate for evaluating the effectiveness of drugs in diabetes mellitus trials: a systematic review and trial-level meta-analysis
-
- Journal:
- International Journal of Technology Assessment in Health Care / Volume 38 / Issue 1 / 2022
- Published online by Cambridge University Press:
- 22 December 2021, e12
-
- Article
- Export citation
PP229 Surrogate Outcomes In Health Technology Assessments Of Oncology Drugs: The Osimertinib Case
-
- Journal:
- International Journal of Technology Assessment in Health Care / Volume 36 / Issue S1 / December 2020
- Published online by Cambridge University Press:
- 28 December 2020, pp. 21-22
-
- Article
-
- You have access
- Export citation
PP21 Use Of Real-World Evidence For Healthcare Decision Making: Infliximab Versus Etanercept And The Risk Of Tuberculosis
-
- Journal:
- International Journal of Technology Assessment in Health Care / Volume 36 / Issue S1 / December 2020
- Published online by Cambridge University Press:
- 28 December 2020, p. 16
-
- Article
-
- You have access
- Export citation